HVIVO
hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. hVIVO changed its name from Retroscreen Virology in April 2015. The business is a plc quoted on the AIM London Stock Exchange (ticker ‘HVO’).
HVIVO
Industry:
Biotechnology Health Care Medical
Founded:
1988-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.hvivo.com
Total Employee:
501+
Status:
Active
Contact:
+44 20 7756 1300
Email Addresses:
[email protected]
Total Funding:
2.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-03-04 | Activiomics | Activiomics acquired by hVIVO | 4 M GBP |
Investors List
Aquarius Equity Partners
Aquarius Equity Partners investment in Series B - hVIVO
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-04-28 | Imutex | hVIVO investment in Seed Round - Imutex | 14 M GBP |
| 2015-11-02 | PrEP Biopharm | hVIVO investment in Series A - PrEP Biopharm | 21 M GBP |
Official Site Inspections
http://www.hvivo.com Semrush global rank: 3.5 M Semrush visits lastest month: 4.26 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "hVIVO"
About Us | World Leaders in Clinical Trials - hVIVO
In January 2020, hVIVO merged with Open Orphan plc, a rapidly growing niche CRO pharmaceutical services company. On 26 October 2022, Open Orphan plc changed its name …See details»
Executive Leadership Team | hVIVO
HVIVO is led by a dynamic group of experts in their respective fields who are driving excellence throughout the organisation. Leadership Team. Board of Directors. Chief Executive Officer. …See details»
hVIVO - Crunchbase Company Profile & Funding
FluCamp is hVIVO's volunteer recruitment brand, recruiting healthy volunteers for human challenge trials to advance medical research in infectious and …See details»
hVIVO - Products, Competitors, Financials, Employees, …
HVIVO is a specialist contract research organization and is involved in conducting human challenge clinical trials for testing infectious and respiratory disease vaccines and …See details»
hVIVO - Funding, Financials, Valuation & Investors - Crunchbase
HVIVO is a contract virology research company that aims to develop antivirals and vaccines in the field of biomedical research. New. Resources. ... How much funding has this organization …See details»
hVIVO (HVO) Investor Relations Material
Jan 29, 2025 hVIVO plc is a contract research organization (CRO) based in the United Kingdom, specializing in the testing of vaccines and antiviral treatments using human challenge clinical …See details»
hVIVO Company Profile | Management and Employees List
HVIVO Profile and History. Founded in 1989 and headquartered in London, UK, hVIVO is a specialty biopharma company with clinical testing capabilities, that is pioneering a human …See details»
hVIVO Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 hVIVO has 5 employees across 2 locations and £11.03 m in annual revenue in FY 2018. See insights on hVIVO including office locations, competitors, revenue, financials, …See details»
Retroscreen Virology Changes its Name to hVIVO
This name change to hVIVO reflects the organisation’s expanded vision and a new human dimension to the way new therapeutic and diagnostics are discovered and developed. Retroscreen Virology Group plc changes to hVIVO plc, and …See details»
Results Centre | Investor Relations - hVIVO
Jan 29, 2025 At hVIVO, our values are more than just words. They are what define us. 01. One Team. We are a diverse group of individuals working for one team to achieve common goals. Each one of us plays a crucial role in the …See details»
hVIVO a world leader in an expanding niche quietly making progress
Mar 21, 2025 One of hVIVO’s standout strengths is its substantial order book. Moving into 2025, it had secured £67 million in contracted revenue, covering a significant portion of its forecasted …See details»
hVIVO Announces Director Update Amid Oncimmune …
Mar 26, 2025 hVIVO plc is a rapidly growing early-stage Contract Research Organisation (CRO) and the global leader in human challenge trials. The company provides comprehensive clinical …See details»
Corporate Governance Code | Investor Relations - hVIVO
The Company has successfully built a drug development consulting and clinical trial services capability in Europe. While this represents the operating capability of the business, its clients …See details»
hVIVO - Overview, News & Similar companies | ZoomInfo.com
Feb 1, 2023 hVIVO contact info: Phone number: +44 2071180727 Website: www.hvivo.com What does hVIVO do? Founded in 1989 and headquartered in London, UK, hVIVO is a …See details»
hVIVO a world leader in an expanding niche quietly making progress
Mar 21, 2025 hVIVO PLC (AIM:HVO) posted record results for 2024, with revenue up 12% and a bumper 26% EBITDA margin. CEO Mo Khan says hVIVO is targeting £73 million in revenue …See details»
hVIVO plc: Governance, Directors and Executives & Committees ...
Nov 5, 2024 hVIVO plc is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and …See details»
Hvivo revenue rose last year as company diversified services
Apr 10, 2025 Looking ahead, Hvivo is guiding revenue of £73 million for the year, with ebitda profit margins expected to be in the mid-high teens as the company integrates its latest …See details»
Environmental, Social & Governance - hVIVO
At hVIVO, we play an important role in improving global health by supporting the clinical development of medicinal products, especially infectious and respiratory disease products, …See details»
hVIVO a world leader in an expanding niche quietly making progress
Mar 21, 2025 One of hVIVO’s standout strengths is its substantial order book. Moving into 2025, it had secured £67 million in contracted revenue, covering a significant portion of its forecasted …See details»
hVIVO Year in Review: Milestones, Growth and 2025 Ambitions
Dec 20, 2024 In our recent interview with Mo Khan, CEO of hVIVO, we reflected on the company’s outstanding achievements in 2024 and gained insights into its ambitious roadmap …See details»